HIV, Immunodeficiencies, Infectious Diseases
Conditions
Keywords
Lymphocytes, Venipuncture, Mononuclear Cells, Natural History
Brief summary
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model....
Detailed description
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model.
Interventions
None listed
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Medstar Health Research Institute
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes
Inclusion criteria
* INCLUSION CRITERIA: * 18 years of age or older. * Adequate venous access. * Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer. * Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000 * Be willing and able to provide written informed consent on screening, comply with study requirements and procedures, and comply with clinic policies * Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, and undergo hepatitis screening
Exclusion criteria
* Pregnant and/or breastfeeding females. * Active substance abuse or history of prior substance abuse that may interfere with protocol compliance or compromise volunteer safety.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The purpose of this protocol is to provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases | Throughout | To provide a mechanism to obtain blood products and other biologic samples that will be used by NIH Intramural Investigators in studies of HIV and other infectious or immune deficiency diseases. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To provide the opportunity to compare genomic and proteomic properties of specimens obtained from individuals living with HIV, other infectious diseases, and other immunodeficiencies with those of healthy volunteers | Throughout | To provide the opportunity to compare genomic and proteomic properties of specimens obtained from individuals living with HIV, other infectious diseases, and other immunodeficiencies with those of healthy volunteers |
Countries
United States
Contacts
CONTACTCatherine A Seamon, R.N.
CONTACTSusan L Moir, Ph.D.
PRINCIPAL_INVESTIGATORSusan L Moir, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Outcome results
None listed